Corporate Governance

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease, migraine and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA^® (dalfampridine) Extended Release Tablets, 10 mg.

Corporate Governance Guidelines

Download

Acorda Corporate Guidelines 66 KB

Code of Ethics

Download

Code of Ethics 194 KB

Committee Charters

Download

Audit Commitee 29 KB

Compensation Committee 26 KB

Nominations & Governance Committee 33 KB

Compliance Committee 20 KB

Research & Development Committee 197 KB

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.

Chairperson